BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 16863564)

  • 1. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
    Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
    Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
    Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
    Ringel-Kulka T; McRorie J; Ringel Y
    Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
    Brenner DM; Chey WD
    Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
    O'Mahony L; McCarthy J; Kelly P; Hurley G; Luo F; Chen K; O'Sullivan GC; Kiely B; Collins JK; Shanahan F; Quigley EM
    Gastroenterology; 2005 Mar; 128(3):541-51. PubMed ID: 15765388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
    Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
    Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
    J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.
    Brenner DM; Moeller MJ; Chey WD; Schoenfeld PS
    Am J Gastroenterol; 2009 Apr; 104(4):1033-49; quiz 1050. PubMed ID: 19277023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V; Gschossmann J; Layer P
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic.
    Charbonneau D; Gibb RD; Quigley EM
    Gut Microbes; 2013; 4(3):201-11. PubMed ID: 23549409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
    Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
    Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR; Jayanthi N; Aasin M; Dhanashri RD; Anirudh T
    Benef Microbes; 2018 Jun; 9(4):563-572. PubMed ID: 29695183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.